1 MIU Colistimethate Sodium For Injection IP

Get a Price/Quote

MOQ : 1 Vial

1 MIU Colistimethate Sodium For Injection IP Specification

Indication
Treatment of life-threatening infections caused by susceptible gram-negative bacteria including Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection

Salt Composition
Colistimethate Sodium 1 Million IU per vial

Origin of Medicine
Allopathic

Drug Type
Prescription

Ingredients
Colistimethate Sodium IP

Physical Form
Lyophilized Powder for Injection

Function
Antibacterial agent for severe infections

Recommended For
Adults and children with serious bacterial infections

Dosage
As prescribed by physician

Dosage Guidelines
To be administered intravenously as per healthcare provider

Suitable For
Suitable for all age groups as directed by physician

Quantity
1 vial

Storage Instructions
Store below 25C, protected from light and moisture

About 1 MIU Colistimethate Sodium For Injection IP

Experience the heroic efficacy of 1 MIU Colistimethate Sodium For Injection IP-a commanding antibacterial option for the treatment of life-threatening gram-negative infections. Now available at a first-rate price cut, this hot deal is ideal for hospitals and clinics ready to order a superior solution. Manufactured by a trusted Indian pharmaceutical supplier, each vial contains premium, lyophilized powder, ensuring first-rate reliability with every dose. Prescription required. Strictly for intravenous use, under medical supervision. Shelf life: 24 months. MRP on request. Don't miss this heroic, life-saving intervention!

Intravenous Application & Guidance

1 MIU Colistimethate Sodium For Injection IP is designed for intravenous injection or infusion, intended for use by healthcare professionals within clinical settings. To prepare, the powder must be reconstituted with sterile water. Directions specify administration as prescribed by the physician, ensuring accurate dosing for patients of any age. Surface of application is limited strictly to intravenous routes, to be handled by trained practitioners for optimal safety and efficacy.

Export, Domestic Reach & Order Fulfillment

Our supply network extends robustly across both main export markets and key domestic territories in India. Efficient order completion and exchange ensure prompt delivery of each vial, offered at a competitive sale price. As a leading distributor, exporter, supplier, and trader, we maintain consistent supply ability to meet varied market demands, securing dependable access for hospitals and clinics seeking this trusted antibacterial agent.

FAQ's of 1 MIU Colistimethate Sodium For Injection IP:

Q: How should 1 MIU Colistimethate Sodium For Injection IP be administered?

A: This product is administered through intravenous injection or infusion, strictly as prescribed by a healthcare provider after reconstitution with sterile water for injection.

Q: What is the main indication for using Colistimethate Sodium Injection?

A: It is indicated for treatment of life-threatening infections caused by susceptible gram-negative bacteria, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.

Q: When should this medication not be used?

A: Colistimethate Sodium injection should not be used in individuals with known hypersensitivity to colistin or polymyxin-class antibiotics.

Q: Where can I purchase or order this product?

A: Colistimethate Sodium vials can be ordered through authorized distributors, exporters, suppliers, and traders in India. Sale price and batch details are available upon request.

Q: What is the process for preparing the injection?

A: The lyophilized powder must be reconstituted with sterile water for injection before intravenous use, following the precise instructions provided by a healthcare professional.

Q: How does this medication benefit patients?

A: Colistimethate Sodium Injection provides a potent antibacterial effect for severe, drug-resistant bacterial infections, supporting recovery in critically ill patients as directed by their physician.

Tell us about your requirement